Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.
about
Therapeutic interventions to disrupt the protein synthetic machinery in melanomaTargeting protein kinase-b3 (akt3) signaling in melanoma.MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.-----------Time-resolved analysis of amino acid stress identifies eIF2 phosphorylation as necessary to inhibit mTORC1 activity in liver.
P2860
Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@ast
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@en
type
label
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@ast
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@en
prefLabel
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@ast
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@en
P2860
P1476
Disruption of Proline Synthesi ...... Mediated by the GCN2 Pathway.
@en
P2093
Gregory R Kardos
Hannah C Wastyk
P2860
P304
P356
10.1158/1541-7786.MCR-15-0048
P577
2015-06-16T00:00:00Z